戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 1417835作成日:2026年10月27日

Trimethylsilyl isocyanate → 1-(4-Methoxyphenyl)-4-[2-(5-aminocarbonylisochroman-1-yl)ethyl]piperazine

https://huagongshe.com/reaction/1417835

反応式

関与物質

役割名称HCID仕込み量
反応物Trimethylsilyl isocyanateHCID 70696—
反応物1-(4-Methoxyphenyl)-4-[2-(5-bromoisochroman-1-yl)ethyl]piperazineHCID 23288744—
反応物HCID 178418306HCID 178418306—
溶媒TetrahydrofuranHCID 8028—
溶媒1,4-DioxaneHCID 31275—
生成物1-(4-Methoxyphenyl)-4-[2-(5-aminocarbonylisochroman-1-yl)ethyl]piperazineHCID 23288829—

反応手順

A mixture of t-butyl lithium (2 eqs, 1.7M in hexane) in THF (2 ml/mmol bromide) is cooled to -78° for 10 minutes before adding the 1-(4-methoxyphenyl)-4-[2-(5-bromoisochroman-1-yl)ethyl]piperazine (LXXIV, EXAMPLE 100) in THF (4 ml/mmol) dropwise over 10 minutes. A freshly distilled solution of trimethylsilylisocyanate (1.5 eqs) is added via syringe as a solution in dioxane (4 volume equivalents) at once. After 15 minutes, the cooling bath is removed and the mixture allowed to warm to 20°-25°. The reaction mixture is quenched with ammonium chloride, the organics are removed under reduced pressure, and the aqueous residue is extracted two times with methylene chloride, dried over sodium sulfate, filtered and concentrated. The crude material is purified by flash chromatography on silica gel. In this manner, 1-(4-methoxyphenyl)-4-[2-(5-bromoisochroman-1-yl)ethyl]piperazine (LXXIV, EXAMPLE 100, 345 mg) is converted to the corresponding amide, the title compound, mp 185°-186°.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US05877317
出典データセットuspto-grants-1999_03
ORD IDord-d878029febda4befa871bebf18ae3d89
出典メモuspto-grants-1999_03